Stoke Therapeutics appoints Alexander “Bo” Cumbo to board after Edward Kaye resigns

• Stoke Therapeutics appointed Alexander (Bo) Cumbo as a Class III director effective Sept. 23, 2026.
• Edward M. Kaye resigned as a Class III director effective Sept. 23, 2026.
• Kaye also stepped down from the board’s Research and Development Committee.
• Cumbo was named to fill the vacancy, with a term running through the 2028 annual meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-402820), on September 25, 2026, and is solely responsible for the information contained therein.